5-AZACITIDINE FIVE DAYS/MONTHLY SCHEDULE IN SYMPTOMATIC LOW-RISK (IPSS: 0-1) MYELODISPLASTIC (MDS) PATIENTS. CLINICAL AND BIOLOGICAL EFFECTS Authors
C. Filì
•
1 M. Gobbi
•
2 G. Martinelli
altro
DAMIANI, Daniela
2010
Periodico
HAEMATOLOGICA
Archivio
Diritti
metadata only access